Trending

Xeris Biopharma enters Research Collaboration and Option Agreement With Horizon Therapeutics November 23, 2022

Manchester United hits 52-Week High on Strategic Alternatives to Enhance the Club’s Growth Announcement November 23, 2022

Kraig Biocraft Laboratories Completes Closeout of $8 Million Financing, Extinguishing All convertible Debentures with Yorkville Advisors November 21, 2022

PaxMedica active on $20 Million Equity Investment Agreement November 18, 2022

CytomX and Regeneron to form Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer November 17, 2022

Next

Prev

$285.54 $5.96 2.04%

$148.11 $2.96 1.96%

$93.41 $0.72 0.76%

$182.86 $0.34 0.19%

$97.60 $1.22 1.23%

Market Movers, Stocks

24/7 Market News – (NASDAQ:RGLS) REGULUS THERAPEUTICS INC. Just announced the FDA orphan drug designation from the FDA.

by 24/7 MarketNews Admin

Jun 21, 2022 at 7:49 AM

Shares are up slightly in pre-market on light trading. currently .30 on only 498 trades.

Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease

https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-receipt-of-fda-orphan-drug-designation-for-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-301571856.html

RelatedNews

Xeris Biopharma enters Research Collaboration and Option Agreement With Horizon Therapeutics

Manchester United hits 52-Week High on Strategic Alternatives to Enhance the Club’s Growth Announcement

Highlights From First FTX Bankruptcy Hearing: “Substantial Amount” Of FTX Assets Stolen, “Dueling” Bahamas Liquidation Comes To A Head

‘In Huge Trouble’—Leak Reveals $10 Billion Earthquake Could Be About To Cause Bitcoin And Ethereum Price Chaos

Kraig Biocraft Laboratories Completes Closeout of $8 Million Financing, Extinguishing All convertible Debentures with Yorkville Advisors

Page 1 of 2

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent News

Xeris Biopharma enters Research Collaboration and Option Agreement With Horizon Therapeutics

November 23, 2022

Manchester United hits 52-Week High on Strategic Alternatives to Enhance the Club’s Growth Announcement

November 23, 2022

Kraig Biocraft Laboratories Completes Closeout of $8 Million Financing, Extinguishing All convertible Debentures with Yorkville Advisors

November 21, 2022

PaxMedica active on $20 Million Equity Investment Agreement

November 18, 2022

CytomX and Regeneron to form Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

November 17, 2022

Follow Us

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

Search by keyword

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations